How to Do Prenatal Checkups in China After IVF in Thailand: Full Process & Transition Guide

Opening: Real Consultation Scenario

Real Consultation Scenario Ms. Li, 32, underwent a fresh embryo transfer at a fertility center in Thailand due to bilateral tubal obstruction. She tested positive for pregnancy on day 12 after the transfer. She plans to return to China in two weeks but is unsure how to transition her prenatal care—which department to visit, what documents to bring, whether the tests differ from natural pregnancy, and whether the tests already done in Thailand will be recognized in China. This is the most common confusion for those returning to China after IVF in Thailand, and this article aims to systematically answer these questions.

1. Prenatal Checkups in China After IVF in Thailand: Core Answer

The core principle for prenatal checkups in China after a successful IVF in Thailand is "medical record transition + project differentiation." Specifically: after returning to China, you should establish a medical record as soon as possible at the obstetrics department or fertility center of a local tertiary hospital, providing the obstetrician with complete records of your embryo details, transfer report, medication protocol, and blood test results from Thailand. In early pregnancy (6–13 weeks), the focus is on confirming fetal heartbeat, excluding ectopic pregnancy, and completing the NT scan. In the second trimester (14–27 weeks), the core is NIPT and systematic anomaly scan. In the third trimester (after 28 weeks), it is largely consistent with routine prenatal care. Key differences lie in the continuation of luteal phase support, adjustment of gestational age calculation, and higher monitoring frequency for twin or multiple pregnancies.

When is it appropriate to follow the standard prenatal checkup process? — Singleton pregnancy, no history of recurrent miscarriage, no pregnancy complications, and tests completed in Thailand (e.g., complete blood count, infectious disease screening, thyroid function) are within validity and reports are complete. When is additional frequency or extra testing needed? — Twin pregnancy, advanced maternal age (≥35), history of miscarriage, PGT indicating chromosomal abnormality risk, or special conditions like uterine abnormalities.

2. Phased Prenatal Checkup Process and Timeline

The following schedule follows the standard gestational weeks used in Chinese obstetrics. For conversion of gestational weeks after transfer in Thailand, see the section "Easily Overlooked Details" below.

3. Easily Overlooked Details

3.1 Transition of Luteal Phase Support

Common luteal phase support medications used in Thailand include progesterone gel (Crinone), oral progesterone (Duphaston), or injectable progesterone. Dosages and methods may differ from those in China. After returning, provide your obstetrician with a written record of the complete medication protocol (drug name, dosage, duration). The doctor will decide whether to adjust or reduce the dose based on gestational age and hormone levels. Stopping or changing the dose on your own may lead to luteal phase insufficiency, increasing the risk of early miscarriage.

3.2 Difference in Gestational Age Calculation

Thailand typically calculates gestational age from the transfer day: the day of fresh embryo transfer is considered 2 weeks + 0 days, while frozen embryo transfer is adjusted based on the embryo stage (D3 or D5). In China, it is uniformly calculated from the first day of the last menstrual period (LMP). Conversion method: for a frozen embryo transfer (D5 blastocyst), subtract 19 days from the transfer day to estimate LMP; for a fresh embryo transfer (D3 embryo), subtract 17 days. An incorrect conversion can lead to mistiming of NT and anomaly scans, so be sure to clarify this with your doctor when establishing your record.

3.3 Validity of Tests Done in Thailand

Thai fertility centers typically require a full set of infectious disease screenings (HIV, syphilis, hepatitis B, hepatitis C), complete blood count, coagulation function, thyroid function, TORCH, etc. These results may be recognized by Chinese hospitals within a certain validity period (usually 6–12 months), but most obstetrics departments will still require some tests to be repeated. It is recommended to bring both the original Thai reports and their English/Chinese translations, and let the doctor decide which can be used directly.

3.4 Providing PGT Results

If you underwent preimplantation genetic testing (PGT-A/PGT-M) in Thailand, the report must be brought back. The obstetrician needs to know if the embryo had any chromosomal abnormalities or if single-gene disease screening was performed. This affects the interpretation of NIPT results and prenatal diagnosis strategies (e.g., the need for amniocentesis).

4. Common Pitfalls

• Incomplete or non-transferred medical records: Some patients only bring the pregnancy test report back, lacking embryo records, transfer reports, and medication protocols. The obstetrician cannot fully understand the IVF pregnancy background, potentially leading to management errors. Before leaving Thailand, request a complete set of medical records (in English or with a Chinese translation), including ovarian stimulation records, egg retrieval records, embryo culture reports, transfer records, and all lab results.
• Not disclosing IVF history: Some patients think "pregnancy is pregnancy" and do not proactively tell their obstetrician they conceived via IVF. This leads to management based on natural pregnancy, ignoring special needs like luteal support, gestational age calculation differences, and twin management. When establishing your record, clearly state "this pregnancy is IVF-assisted" and provide the contact information of the Thai fertility center for verification.
• Inappropriate choice of NIPT: For twin pregnancies, if the doctor is not informed, the lab may analyze using a singleton algorithm, leading to unreliable results. Similarly, if PGT results indicate mosaicism or copy number variants, NIPT may not cover these, and direct prenatal diagnosis is needed. Always fully discuss your IVF background with your doctor before choosing NIPT.
• Wrong timing for reducing luteal support: Some Chinese obstetricians may have limited experience managing luteal support for IVF pregnancies and may stop or reduce medication too early. Generally, luteal support is recommended until weeks 10–12 (after placental formation), but the specific plan needs individual adjustment and should not be decided independently.
• Ignoring the need for psychological support: Anxiety levels after IVF are generally higher than in natural pregnancies, and some patients become overly nervous about each prenatal visit. This can affect blood pressure and endocrine status. It is advisable to actively seek psychological support or join communities of IVF mothers during the prenatal process.

5. Interpretation of Test Indicators: Special Focus for IVF Pregnancy

IVF pregnancies may differ from natural pregnancies in certain test indicators. Understanding these differences can help avoid unnecessary anxiety.

6. Special Situations

6.1 Twin Pregnancy

The rate of double embryo transfer is relatively high in Thailand, with twin pregnancies accounting for about 20%–30% of IVF cases. Twin pregnancies require more intensive prenatal care: early confirmation of chorionicity (monochorionic twins have higher complication risks); NT scan completed at 11–13⁺⁶ weeks by an experienced sonographer; mid-trimester anomaly scan recommended at a tertiary hospital, possibly with fetal echocardiography; cervical length measurement starting from week 16, every 2–4 weeks, with cervical cerclage considered if length <25 mm. The risk of preterm birth is significantly increased, so discuss neonatal support conditions with the hospital in advance.

6.2 Advanced Maternal Age (≥35)

Advanced age is a common indication for IVF and a key factor in prenatal care. The risk of chromosomal abnormalities increases in women over 35, so direct prenatal diagnosis (amniocentesis) is recommended rather than NIPT alone. Additionally, the risk of pregnancy-induced hypertension, diabetes, and placental insufficiency increases, so the frequency of prenatal visits should be appropriately increased, with weekly NST in the third trimester.

6.3 History of Recurrent Miscarriage

For patients with a history of recurrent miscarriage who return to China after a successful IVF in Thailand, special attention should be paid to luteal function, thyroid function, coagulation function, and immune factors. It is recommended to check HCG and progesterone weekly in early pregnancy (weeks 6–10) and adjust management based on uterine artery blood flow, antiphospholipid antibodies, etc. If necessary, anticoagulation therapy with low molecular weight heparin or aspirin may be used, but only under the joint guidance of an obstetrician and reproductive specialist.

6.4 PGT Indicating Chromosomal Abnormality Risk

If the PGT report from Thailand indicates mosaicism, copy number variants, or single-gene disease carrier status, prenatal diagnosis (amniocentesis or chorionic villus sampling) is mandatory upon returning to China; NIPT cannot replace it. Amniocentesis is recommended at weeks 16–18, along with chromosomal karyotyping and genetic testing. Such cases require the involvement of a genetic counselor to develop a follow-up monitoring plan.

7. Frequently Asked Questions

• Q: Are ultrasound reports from Thailand recognized by Chinese hospitals?
  A: Ultrasound reports (in English) from reputable Thai fertility centers are generally recognized by tertiary hospitals in China, but a baseline ultrasound will still be required when establishing your record. It is advisable to choose a hospital with an international medical department for smoother coordination.
• Q: Can I go directly to a community hospital for prenatal checkups after returning to China?
  A: It is recommended to establish your record at the obstetrics department or fertility center of a tertiary hospital. IVF pregnancy is considered high-risk, and community hospitals may lack the capacity for twin management, prenatal diagnosis, etc.
• Q: What is the approximate cost of prenatal checkups in China after a successful IVF in Thailand?
  A: Routine prenatal care (including NIPT, major anomaly scan, OGTT, etc.) at a tertiary hospital costs about 8,000–12,000 RMB in total. Costs are higher for twins or advanced age requiring additional tests. Medical insurance covers some basic items, but NIPT and amniocentesis are often self-funded.
• Q: How soon after transfer is it appropriate to return to China?
  A: It is generally recommended to confirm pregnancy with a test 12–14 days after transfer, then observe for 3–5 days without any abnormalities (no abdominal pain, bleeding, etc.) before returning. The earliest departure can be around 2 weeks after transfer.

8. Practitioner's Observation

In years of patient education in assisted reproduction, I have observed a typical pattern: some patients think "after IVF success, it's just like a natural pregnancy," overlooking the special aspects of IVF in gestational age calculation, luteal support, and psychological stress. Others become overly anxious, requesting unnecessary additional tests at every visit, which only increases anxiety and costs. Both extremes should be avoided.

The core of prenatal checkups in China after IVF in Thailand is not "the more tests, the better," but "precise transition + focused priorities." Bringing back complete medical records from Thailand, proactively communicating your IVF background with the obstetrician, completing key tests according to the standard schedule, and making individualized adjustments based on age, embryo status, and number of pregnancies—this is the safest path.

Additionally, I recommend that all patients returning to China after IVF in Thailand undergo a comprehensive obstetric evaluation in early pregnancy (weeks 8–10), including baseline blood pressure, blood glucose, thyroid function, and coagulation function. This not only helps detect potential problems early but also allows the obstetrician to have a fuller understanding of your health status.

This article is based on general consensus in assisted reproductive medicine and is not intended as individualized medical advice. Please develop your specific prenatal plan with your obstetrician.